OMX Nordic 40
|
2 352,20
|
-6,52
|
-0,28 %
|
Analysen zu OMX Nordic 40-Werten
| 03.02.25 | Hennes & Mauritz AB Underperform | Bernstein Research | |
| 03.02.25 | Hennes & Mauritz AB Sector Perform | RBC Capital Markets | |
| 03.02.25 | Ericsson Sell | Goldman Sachs Group Inc. | |
| 03.02.25 | Volvo AB Buy | Jefferies & Company Inc. | |
| 03.02.25 | Nokia Hold | Jefferies & Company Inc. | |
| 31.01.25 | ABB Sell | Deutsche Bank AG | |
| 31.01.25 | Nokia Neutral | UBS AG | |
| 31.01.25 | Nokia Buy | Deutsche Bank AG | |
| 31.01.25 | Nokia Sell | Goldman Sachs Group Inc. | |
| 31.01.25 | Hennes & Mauritz AB Sell | Goldman Sachs Group Inc. | |
| 31.01.25 | ABB Neutral | UBS AG | |
| 30.01.25 | Hennes & Mauritz AB Underweight | JP Morgan Chase & Co. | |
| 30.01.25 | Volvo AB Buy | Deutsche Bank AG | |
| 30.01.25 | Ericsson Neutral | JP Morgan Chase & Co. | |
| 30.01.25 | Nokia Market-Perform | Bernstein Research | |
| 30.01.25 | ABB Underperform | Bernstein Research | |
| 30.01.25 | Volvo AB Neutral | UBS AG | |
| 30.01.25 | AstraZeneca Neutral | UBS AG | |
| 30.01.25 | Nokia Overweight | JP Morgan Chase & Co. | |
| 30.01.25 | ABB Neutral | UBS AG | |
| 30.01.25 | Nokia Neutral | UBS AG | |
| 30.01.25 | Hennes & Mauritz AB Buy | UBS AG | |
| 30.01.25 | Hennes & Mauritz AB Sell | Goldman Sachs Group Inc. | |
| 30.01.25 | Nokia Sell | Goldman Sachs Group Inc. | |
| 30.01.25 | Hennes & Mauritz AB Sector Perform | RBC Capital Markets | |
| 30.01.25 | ABB Neutral | Goldman Sachs Group Inc. | |
| 30.01.25 | ABB Sector Perform | RBC Capital Markets | |
| 29.01.25 | Novo Nordisk Buy | UBS AG | |
| 29.01.25 | Volvo AB Sector Perform | RBC Capital Markets | |
| 29.01.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 29.01.25 | Volvo AB Neutral | UBS AG | |
| 29.01.25 | Ericsson Hold | Deutsche Bank AG | |
| 29.01.25 | Volvo AB Buy | Goldman Sachs Group Inc. | |
| 29.01.25 | Volvo AB Overweight | JP Morgan Chase & Co. | |
| 28.01.25 | Nokia Overweight | JP Morgan Chase & Co. | |
| 28.01.25 | ABB Underperform | Bernstein Research | |
| 28.01.25 | Novo Nordisk Buy | UBS AG | |
| 27.01.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 27.01.25 | Hennes & Mauritz AB Underweight | JP Morgan Chase & Co. | |
| 27.01.25 | Hennes & Mauritz AB Hold | Jefferies & Company Inc. |